251 related articles for article (PubMed ID: 6376640)
1. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
Gammon WR; Inman AO; Wheeler CE
J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
[TBL] [Abstract][Full Text] [Related]
2. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita.
Gammon WR; Briggaman RA
J Invest Dermatol; 1987 Nov; 89(5):478-83. PubMed ID: 3668292
[TBL] [Abstract][Full Text] [Related]
3. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
[TBL] [Abstract][Full Text] [Related]
4. Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen.
Furue M; Iwata M; Tamaki K; Ishibashi Y
Br J Dermatol; 1986 Jun; 114(6):651-9. PubMed ID: 3521710
[TBL] [Abstract][Full Text] [Related]
5. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
Fine JD
J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
[TBL] [Abstract][Full Text] [Related]
6. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
[TBL] [Abstract][Full Text] [Related]
7. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
Gammon WR; Woodley DT; Dole KC; Briggaman RA
J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
[TBL] [Abstract][Full Text] [Related]
8. Expression of extracellular and intracellular bullous pemphigoid antigens at the dermal-epibolic junction in organ culture of human skin.
Ikeda S; Yaguchi H; Ogawa H
J Invest Dermatol; 1990 Mar; 94(3):336-40. PubMed ID: 2407787
[TBL] [Abstract][Full Text] [Related]
9. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
Mooney E; Falk RJ; Gammon WR
Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
[TBL] [Abstract][Full Text] [Related]
10. Localization of bullous pemphigoid antibody--an indirect immunofluorescence study of 228 cases using a split-skin technique.
Logan RA; Bhogal B; Das AK; McKee PM; Black MM
Br J Dermatol; 1987 Oct; 117(4):471-8. PubMed ID: 3314971
[TBL] [Abstract][Full Text] [Related]
11. Epidermolysis bullosa acquisita--a pemphigoid-like disease.
Gammon WR; Briggaman RA; Woodley DT; Heald PW; Wheeler CE
J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):820-32. PubMed ID: 6392361
[TBL] [Abstract][Full Text] [Related]
12. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
Peng TK; Nisengard RJ; Levine MJ; Beutner EH
Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
[TBL] [Abstract][Full Text] [Related]
13. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE
J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J
J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015
[No Abstract] [Full Text] [Related]
16. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
Iwatsuki K; Tagami H; Yamada M
Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
[TBL] [Abstract][Full Text] [Related]
17. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
Woźniak K; Kowalewski C
J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
[TBL] [Abstract][Full Text] [Related]
18. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
[TBL] [Abstract][Full Text] [Related]
19. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
Briggaman RA; Gammon WR; Woodley DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
[TBL] [Abstract][Full Text] [Related]
20. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
Jenkins RE; Rodenas J; Bhogal BS; Black MM
Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
